The Company plans to provide updated revenue and adjusted operating expenses guidance during its third quarter 2025 earnings call, taking into account the factors discussed in this press release.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT:
- Sight Sciences price target lowered to $4 from $4.50 at Citi
- Sight Sciences Amends Loan Agreement with Hercules
- Sight Sciences announces publication of results on OMNI Surgical System
- Sight Sciences: Balancing Resilience in Glaucoma Market with Reimbursement Challenges – Hold Rating Justified
- Needham medtech & diagnostics analysts hold analyst/industry conference call